Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Nov;35(11):2923–2926. doi: 10.1128/jcm.35.11.2923-2926.1997

Decreased capacity for type-specific-antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico.

G C Palacios 1, E K Eskew 1, F Solorzano 1, S J Mattingly 1
PMCID: PMC230088  PMID: 9350760

Abstract

The low incidence of group B streptococcal (GBS) invasive neonatal disease in Mexico has been attributed to the low prevalence of serotype III strains, a major serotype in developed countries. In addition, nontypeable strains account for 12% of the isolates in Mexico and < 1% of the isolates in the United States. In this study, 57 GBS isolates (28 nontypeable by the Lancefield procedure) from carrier and infected neonates and women from Mexico were also examined for the presence of type-specific antigen by an enzymatic procedure using N-acetylmuramidase digestion of the cell wall to release soluble type-specific antigen. Of the 28 nontypeable strains from Mexico, 23 were typeable by the enzyme extraction procedure, with serotype III being the predominant serotype in invasive disease. These results suggest that nontypeable isolates of GBS should be further examined by the enzymatic extraction procedure to determine the presence of type-specific antigen. Furthermore, these limited results suggest that serotype III is likely a major serotype in invasive disease also in Mexico.

Full Text

The Full Text of this article is available as a PDF (380.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carey R. B., Eisenstein T. K., Shockman G. D., Greber T. F., Swenson R. M. Soluble group- and type-specific antigens from type III group B Streptococcus. Infect Immun. 1980 Apr;28(1):195–203. doi: 10.1128/iai.28.1.195-203.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. De Cueninck B. J., Shockman G. D., Swenson R. M. Group B, type III streptococcal cell wall: composition and structural aspects revealed through endo-N-acetylmuramidase-catalyzed hydrolysis. Infect Immun. 1982 Feb;35(2):572–581. doi: 10.1128/iai.35.2.572-581.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Doran T. I., Mattingly S. J. Association of type- and group-specific antigens with the cell wall of serotype III group B streptococcus. Infect Immun. 1982 Jun;36(3):1115–1122. doi: 10.1128/iai.36.3.1115-1122.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Doran T. I., Straus D. C., Mattingly S. J. Factors influencing release of type III antigens by group B streptococci. Infect Immun. 1981 Feb;31(2):615–623. doi: 10.1128/iai.31.2.615-623.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Milligan T. W., Doran T. I., Straus D. C., Mattingly S. J. Growth and amino acid requirements of various strains of group B streptococci. J Clin Microbiol. 1978 Jan;7(1):28–33. doi: 10.1128/jcm.7.1.28-33.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Schuchat A., Wenger J. D. Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. Epidemiol Rev. 1994;16(2):374–402. doi: 10.1093/oxfordjournals.epirev.a036159. [DOI] [PubMed] [Google Scholar]
  7. Solorzano-Santos F., Echaniz-Aviles G., Conde-Glez C. J., Calderon-Jaimes E., Arredondo-Garcia J. L., Beltran-Zuniga M. Cervicovaginal infection with group B streptococci among pregnant Mexican women. J Infect Dis. 1989 May;159(5):1003–1004. doi: 10.1093/infdis/159.5.1003. [DOI] [PubMed] [Google Scholar]
  8. Solórzano-Santos F., Díaz-Ramos R. D., Arredondo-García J. L. Diseases caused by group B Streptococcus in Mexico. Pediatr Infect Dis J. 1990 Jan;9(1):66–66. doi: 10.1097/00006454-199001000-00019. [DOI] [PubMed] [Google Scholar]
  9. WARREN L., BLACKLOW R. S. The biosynthesis of cytidine 5'-monophospho-n-acetylneuraminic acid by an enzyme from Neisseria meningitidis. J Biol Chem. 1962 Nov;237:3527–3534. [PubMed] [Google Scholar]
  10. Walsh J. A., Hutchins S. Group B streptococcal disease: its importance in the developing world and prospect for prevention with vaccines. Pediatr Infect Dis J. 1989 May;8(5):271–277. [PubMed] [Google Scholar]
  11. Wessels M. R., Pozsgay V., Kasper D. L., Jennings H. J. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem. 1987 Jun 15;262(17):8262–8267. [PubMed] [Google Scholar]
  12. Wilkinson H. W., Facklam R. R., Wortham E. C. Distribution by serological type of group B streptococci isolated from a variety of clinical material over a five-year period (with special reference to neonatal sepsis and meningitis). Infect Immun. 1973 Aug;8(2):228–235. doi: 10.1128/iai.8.2.228-235.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Yeung M. K., Mattingly S. J. Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect Immun. 1984 May;44(2):217–221. doi: 10.1128/iai.44.2.217-221.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Yeung M. K., Mattingly S. J. Isolation and characterization of type III group B streptococcal mutants defective in biosynthesis of the type-specific antigen. Infect Immun. 1983 Oct;42(1):141–151. doi: 10.1128/iai.42.1.141-151.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. de Lourdes Collado M., Kretschmer R. R., Becker I., Guzmán A., Gallardo L., Lepe C. M. Colonization of Mexican pregnant women with group B streptococcus. J Infect Dis. 1981 Jan;143(1):134–134. doi: 10.1093/infdis/143.1.134. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES